Live Quote · NASDAQAYTUHealthcare· Drug Manufacturers - Specialty & Generic

Aytu BioPharma, Inc.

$2.16 0.23%(+$0.00)
TickerSpark Score
53/100
Mixed
80
Valuation
40
Profitability
65
Growth
48
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AYTU research report →

52-Week Range36% of range
Low
$1.65
Current
$2.16
High
$3.07
Company Overviewaytubio.com

About the company

Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U. S.

CEO
Joshua R. Disbrow
IPO
2008
Employees
102
HQ
Englewood, CO, US

Price Chart

-5.68% · this period
$2.90$2.30$1.71Jul 02Dec 31Jul 02
Valuation
Market Cap
$17.49M
P/E
-0.67
P/S
0.31
P/B
0.65
EV/EBITDA
-0.50
Div Yield
0.00%
Profitability
Gross Margin
62.50%
Op Margin
-26.79%
Net Margin
-60.17%
ROE
-148.91%
ROIC
-23.62%
Growth & Income
Revenue
$66.38M · 1.84%
Net Income
$-13,562,000 · 14.40%
EPS
$-2.16 · 24.48%
Op Income
$-7,827,000
FCF YoY
-200.82%
Performance & Tape
52W High
$3.07
52W Low
$1.65
50D MA
$2.29
200D MA
$2.37
Beta
0.24
Avg Volume
38.00K

Get TickerSpark's AI analysis on AYTU

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 30, 25DOCKERY CARLother0
Oct 3, 25PYSZCZYMUKA GREGother12,500
Oct 3, 25Disbrow Jarrettother12,500
Oct 3, 25Disbrow Jarrettother19,606
Oct 3, 25Selhorn Ryan Jother17,500
Oct 3, 25Selhorn Ryan Jother16,243
Oct 3, 25Disbrow Joshua R.other22,500
Oct 3, 25Disbrow Joshua R.other31,446
Oct 3, 25LIU VIVIAN Hother10,000
Oct 3, 25JAIN ABHINAVother10,000
Coverage · AYTU

Our AYTU coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on AYTU yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate AYTU report →
Internal Compare

Similar companies

Peers in the same neighborhood.